Published ahead of print on January 10, 2003, doi:10.1165/rcmb.2002-0074OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 12-18, 2003
© 2003 American Thoracic Society DOI: 10.1165/rcmb.2002-0074OC
Effects of Transforming Growth Factor-ß and Budesonide on Mitogen-Activated Protein Kinase Activation and Apoptosis in Airway Epithelial Cells
Girolamo Pelaia*,
Giovanni Cuda*,
Alessandro Vatrella,
Donatella Fratto,
Rosa D. Grembiale,
Pierosandro Tagliaferri,
Rosario Maselli,
Francesco S. Costanzo and
Serafino A. Marsico
Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Catanzaro; and Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Naples, Italy
Address correspondence to: Dr. Girolamo Pelaia, M.D., Policlinico Universitario "Mater Domini," Via T. Campanella, 88100 Catanzaro, Italy. E-mail: pelaia{at}unicz.it
Airway epithelial cells play a central role in the inflammatory, apoptotic, and remodeling processes associated with asthma. Within this context, a key function is exerted by transforming growth factor-ß (TGF-ß), whose biological effects are mediated at least in part by mitogen-activated protein kinases (MAPKs). The aim of our study was to investigate, in primary cultures of human bronchial epithelial cells (HBEC), the effects of TGF-ß (10 ng/ml) on both MAPK activation and apoptosis, in the presence or absence of a pretreatment with budesonide (10-8 M). MAPK activation was detected by Western blotting, using antiphospho-MAPK monoclonal antibodies, which specifically recognize the phosphorylated, active forms of these enzymes. Apoptosis was assayed by caspase-3 activation and fluorescence microscopy, using annexin-V (An-V) and propidium iodide (PI) as markers of cell death. Our results show that TGF-ß induced a marked ( 9-fold) increase in p38 MAPK phosphorylation, and also dramatically enhanced cell death, which was completely prevented by specific MAPK inhibitors. Both MAPK activation and apoptosis were effectively inhibited by budesonide (BUD), thereby suggesting that the powerful antiapoptotic action of inhaled glucocorticoids may be very important for their protective role against epithelial injury, which represents a key pathogenic event in asthma.
Abbreviations: Annexin-V, An-V budesonide, BUD extracellular signalregulated kinases, ERK human bronchial epithelial cells, HBECs c-Jun N-terminal kinases, JNK mitogen-activated protein kinase, MAPK propidium iodide, PI sodium dodecyl sulfate, SDS transforming growth factor-ß, TGF-ß
This article has been cited by other articles:

|
 |

|
 |
 
H. J. Kim, Y.-D. Park, U. Y. Moon, J.-H. Kim, J. H. Jeon, J.-G. Lee, Y. S. Bae, and J.-H. Yoon
The Role of Nox4 in Oxidative Stress-Induced MUC5AC Overexpression in Human Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
November 1, 2008;
39(5):
598 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Murphy, I. A. Forrest, P. A. Corris, G. E. Johnson, T. Small, D. Jones, A. J. Fisher, J. J. Egan, T. E. Cawston, C. Ward, et al.
Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients
Am J Physiol Lung Cell Mol Physiol,
March 1, 2008;
294(3):
L592 - L599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward
Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
Eur. Respir. J.,
September 1, 2007;
30(3):
574 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tesfaigzi
Roles of Apoptosis in Airway Epithelia
Am. J. Respir. Cell Mol. Biol.,
May 1, 2006;
34(5):
537 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bao and D. L. Knoell
Zinc modulates airway epithelium susceptibility to death receptor-mediated apoptosis
Am J Physiol Lung Cell Mol Physiol,
March 1, 2006;
290(3):
L433 - L441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Chu, S. Balzar, G. J. Seedorf, J. Y. Westcott, J. B. Trudeau, P. Silkoff, and S. E. Wenzel
Transforming Growth Factor-{beta}2 Induces Bronchial Epithelial Mucin Expression in Asthma
Am. J. Pathol.,
October 1, 2004;
165(4):
1097 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Undevia, D. R. Dorscheid, B. A. Marroquin, W. L. Gugliotta, R. Tse, and S. R. White
Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-{beta}1 in human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol,
September 1, 2004;
287(3):
L515 - L524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Lee, S. J. Cho, M. J. Kang, S. P. Chapoval, P. J. Lee, P. W. Noble, T. Yehualaeshet, B. Lu, R. A. Flavell, J. Milbrandt, et al.
Early Growth Response Gene 1-mediated Apoptosis Is Essential for Transforming Growth Factor {beta}1-induced Pulmonary Fibrosis
J. Exp. Med.,
August 2, 2004;
200(3):
377 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. O'Sullivan, J. W. Tyner, and M. J. Holtzman
Apoptosis in the Airways: Another Balancing Act in the Epithelial Program
Am. J. Respir. Cell Mol. Biol.,
July 1, 2003;
29(1):
3 - 7.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|